Does Dr. KEZIA ALBERTO have financial conflicts of interest?

Dr. KEZIA ALBERTO (M.D.) has received a total of $5,181 in pharmaceutical and medical device industry funding between 2021 and 2024. This includes $5,181 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. KEZIA ALBERTO?

According to CMS Open Payments data, Dr. KEZIA ALBERTO received funding from ASTRAZENECA PHARMACEUTICALS ($1,028), VIFOR PHARMA ($1,013), and GLAXOSMITHKLINE ($608).

Does Dr. KEZIA ALBERTO receive research grants or speaking fees?

Dr. KEZIA ALBERTO has received $5,181 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. KEZIA ALBERTO

M.D.Real-Time Hydrated

Specialty: Internal Medicine, Nephrology

Practice Location: FLORHAM PARK, NJ 07932

NPI Number: 1073721809

LIFETIME INDUSTRY VALUE

$5,181

2021 – 2024 Cumulative

Conflict of Interest Analysis

Dr. ALBERTO is a verified Internal Medicine, Nephrology practitioner based in FLORHAM PARK, NJ.

Between 2021 and 2024, Dr. ALBERTO had an overall industry promotional and research financial footprint of $5,181 as recorded in the federal CMS Open Payments database.

$5,181 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. ALBERTO's primary funding source is ASTRAZENECA PHARMACEUTICALS, which accounts for $1,028 (representing 19.8% of overall industry footprint).

Data coverage: 2021 – 2024 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

ASTRAZENECA PHARMACEUTICALS

Rank 1

$1,028

19.8%

VIFOR PHARMA

Rank 2

$1,013

19.6%

GLAXOSMITHKLINE

Rank 3

$608

11.7%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2024

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.